Fineotex Chemical Limited (FCL) has announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. For the consolidated Q3-FY 2025-2026, the company reported revenue from operations of ₹13,771 Lakhs, maintaining stability compared to the previous quarter’s ₹13,707 Lakhs, reflecting a marginal growth of 0.47%. The consolidated Profit After Tax (PAT) for the quarter grew to ₹2,608 Lakhs from ₹2,503 Lakhs in the previous quarter, a growth of 4.19%. Compared to the corresponding quarter of the previous year, the revenue showed a steady trend while the profit margin improved due to operational efficiencies. The company’s operational EBITDA for the quarter stood at ₹3,103 Lakhs, a significant 23.13% increase from the previous quarter, demonstrating strong operational management.

*Note: YoY percentages are based on cumulative annual growth trends reported for the 2025 period.

Fineotex Chemical Limited is a leading Indian multinational manufacturer of specialty performance chemicals, serving sectors such as textiles, home care, hygiene, and oil and gas. In 2025, the company reached several milestones, including the inauguration of its new corporate office in Mumbai and receiving the prestigious “Two Star Export House” status from the Ministry of Commerce. FCL has been actively expanding its footprint, notably through the strategic acquisition of a leading U.S. specialty oilfield chemicals group in late 2025. The company also successfully commissioned its fourth plant in Ambernath in August 2025, adding 15,000 MTPA to its capacity. In terms of corporate actions, FCL implemented a 1:2 stock split and a 4:1 bonus issue in October 2025 to enhance market liquidity. Notable investors in the company include Ashish Kacholia, who held a 2.58% stake as of early 2026, and Suresh Kumar Agarwal with a 1.20% stake. The company continues to focus on sustainable chemistry and has received NABL accreditation for its R&D laboratory for the third consecutive year in 2025.